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The Editorial on the Research Topic 
Epigenetics of B Cells and Antibody Responses
Epigenetics is the study of changes in gene activity that are heritable but not caused by changes in 
the DNA sequence. By modulating gene activities, epigenetic changes regulate cell functions. They 
include DNA methylation, histone post-translational modifications, and gene silencing by the action 
of non-coding RNAs, particularly microRNAs. It is now clear that epigenetic changes regulate B 
cell development. By acting in concert with networks of transcription factors, they modulate the 
activation of B cell lineage-specific gene programs and repress inappropriate gene transcription in 
particular B cell differentiation states (1).
The hallmark of B cell development in the bone marrow is the assembly of the B cell receptor 
(BCR) for antigen through rearrangement of immunoglobulin heavy (IgH) and light (IgL) chain 
V(D)J genes, as mediated by RAG1/RAG2 recombinases. Ig V(D)J rearrangement critically times 
the progression from pro-B cell to pre-B cell and, eventually, transitional and mature B cell. Such 
progression is modulated by epigenetic marks, such as DNA methylation and histone posttransla-
tional modifications, which increase chromatin accessibility and target RAG1/RAG2 to V, D, and J 
DNA (2). It is also dependent on the expression of epigenetic factors, such as microRNAs. In mice 
deficient in Ago2, which is essential for microRNA biogenesis and function, B cell development is 
arrested at the pro-B cell stage (Danger et al.). Accordingly, B cell-specific ablation of microRNAs 
by B cell-specific knockout of Dicer virtually blocks B cell differentiation at the pro-B to pre-B cell 
transition (Danger et al.).
After mature B cells encounter antigen, changes of the epigenetic landscape are induced by the 
same stimuli that drive the antibody response. Such epigenetic changes underpin the maturation 
of the antibody response itself. They instruct those B cell differentiation processes, somatic hyper-
mutation (SHM), class-switch DNA recombination (CSR), and plasma cell differentiation that are 
central to the maturation of the antibody response as well as the differentiation of memory B cells. 
Inducible histone modifications, together with DNA methylation and microRNAs, modulate the 
transcriptome, particularly the expression of activation-induced cytidine deaminase (AID), central 
to SHM and CSR, and B lymphocyte-induced maturation protein-1 (Blimp-1), the master transcrip-
tion factor in plasma cell differentiation (1, 3–5) (Shen et al. and Zan and Casali).
Combinatorial histone modifications also function as histone codes in targeting the CSR and, 
possibly, the SHM machinery to the Ig locus by recruiting specific adaptors (histone code readers) 
that can in turn target and/or stabilize CSR/SHM factors (6). Epigenetic alterations in memory B 
cells contribute to their functional distinction from their naive counterparts. Memory B cells inherit 
epigenetic information from their precursors and acquire new epigenetic marks, which make these 
resting B cells poised to promptly respond to antigen. The cross/feedback regulation of different 
epigenetic modifications/elements further increases the complexity of the B cell epigenome, which 
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interacts with the genetic information for precise modulation 
of gene expression. It is increasingly evident that epigenetic 
dysregulation in B cells, including aberrant expression of micro-
RNAs, can result in aberrant antibody responses to microbial 
pathogens, emergence of pathogenic autoantibodies or B cell 
neoplastic transformation. Epigenetic marks are potential targets 
for new therapeutics in autoimmunity and B cell malignancy. The 
collection of experimental and review articles in this research 
topic addresses from different perspectives the role of epigenetic 
mechanisms in B cell function and antibody responses.
Zan and Casali presented an overview of the role of epigenet-
ics in CSR, SHM, and B cell differentiation to plasma cells and 
memory B cells, and therefore, the regulation and maturation of 
the antibody response. They also highlight our current under-
standing of epigenetic modulations of CSR, SHM, and plasma cell 
differentiation by HDAC inhibitors. By performing genome-wide 
analysis of B cells that are induced to undergo CSR and plasma 
cells differentiation, Shen et al. further extended their recent dis-
covery showing that HDAC inhibitors modulate the expression 
of AID and Blimp-1 by regulating the microRNAs that silence 
Aicda and Prdm1. This work reveals selective modulation of 
microRNAs and mRNAs by HDAC inhibitors.
During B cell development, only one allele of the BCR H chain 
and κ chain or λ chain locus undergoes V(D)J rearrangement at 
a time, and once productive rearrangement is sensed, rearrange-
ment of the second allele is prevented. Levin-Klein and Bergman 
summarized recent advances in our understanding of the mecha-
nisms specifying allelic exclusion of antigen receptor genes. They 
discussed the epigenetic processes, including asynchronous rep-
lication, nuclear localization, chromatin condensation, histone 
modifications, and DNA methylation, which appear to regulate 
the primary rearrangement of a single allele, while blocking the 
rearrangement of the second allele.
In immunoglobulins, juxtaposition of the three complemen-
tary-determining regions (CDRs) of the L chain and the three 
of the H chain creates the site that binds antigen. While the 
CDR1 and the CDR2 are encoded by germline sequences and 
the CDRL3 is largely so, the CDRH3, which provides the most 
critical structure basis for antigen binding, is the product of mul-
tiple VDJ rearrangements and multiple unencoded N nucleotide 
insertions. This makes CDRH3 the most diverse component of 
pre-immune Ig repertoire. The diversity of CDRH3 is constrained 
by natural selection of Ig DH sequence. Restricted D gene usage 
leads to defective T-dependent immune responses. By utilizing 
elegant genetic mouse models and defined B cell response assays, 
Trad et  al. showed that T-dependent B cell responses can be 
heavily influenced by the effects of natural selection of the D on 
CDRH3 repertoire diversity. They provided strong evidence that 
the antigen-independent usage of the D gene segments during 
VDJ recombination plays a role in modulating the affinity matu-
ration in antigen-dependent B cell responses.
Class-switch DNA recombination is a tightly controlled mul-
tistep process involving transcription through switch regions, the 
DNA cytidine deaminase AID and the participation of several 
general DNA repair pathways. Vaidyanathan and Chaudhuri 
reviewed the multilevels of epigenetic regulation that orchestrate 
CSR, and thoroughly discussed epigenetic controls of switch 
region accessibility, the epigenetic regulation of AID expression 
and targeting, as well as of subsequent events of DNA repair.
Expression of AID is tightly regulated due to its mutagenic and 
recombinogenic potential. AID is known to target not only Ig genes 
but also non-Ig genes, thereby contributing to lymphomagenesis. 
In addition to the essential role of AID in CSR and SHM, a new 
epigenetic function of AID and its link to DNA demethylation has 
came to light in several developmental systems. Dominguez and 
Shaknovich summarized existing evidence linking deamination 
of unmodified and modified cytidine by AID to base-excision 
repair and mismatch repair machinery resulting in passive or 
active removal of DNA methylation mark, with the focus on B 
cell function. They also discuss potential contribution of AID-
dependent DNA hypomethylation to B lymphomagenesis.
Transitional B cells (T1 and T2) are selected to avoid self-
reactivity and to safeguard against autoimmunity, then differenti-
ate into mature follicular (FO-I and FO-II) and marginal zone 
(MZ) B cells. To understand how gene expression coordinates 
transitional B cell tolerance and mature B cell fate, Kleiman et al. 
performed a comprehensive transcriptome analysis of T1, T2, 
FO-I, FO-II, and MZ B cell subsets by next-generation RNA-Seq. 
They identified several genes and gene clusters that are likely 
linked to specific B cell subsets and transitions of different B cell 
differentiation stages and their functions.
Understanding the regulation of antibody production and B 
cell memory formation and function is core to find new treat-
ments for antibody-mediated autoimmune diseases, immunode-
ficiencies, and B cell-derived cancers. Progression from a small 
number of antigen-specific B cells to the production of a large 
number of antibody-secreting cells is tightly regulated. Although 
much progress has been made in revealing the transcriptional 
regulation of B cell differentiation that occurs during antibody 
responses, there are still many questions that remain to be 
answered. Recent work on the expression and roles of histone 
modifications in lymphocytes has begun to shed light on this 
additional level of regulation. Good-Jacobson discussed the 
recent advancements in understanding how antibody responses, 
in particular germinal centers and memory B cells, are modulated 
by histone modifications.
Heterochromatin protein 1γ (HP-1γ) is a highly conserved 
component of chromatin. It recognizes H3K9 methylation 
through a chromo-domain and is involved in transcription 
elongation. In vitro observations suggest a role for HP-1γ in the 
immune system. However, it has not been shown if and how 
HP-1γ contributes to immunity in  vivo. Ha et  al. uncovered a 
novel molecular pathway that regulates the adaptive immune 
response to T-dependent antigens. They demonstrated that HP-1γ 
positively controls the germinal center reaction and maturation 
of the high-affinity antibody response by modulating the size of 
the CD8+ Treg compartment.
Eukaryotic cells contain a variety of intracellular membranes, 
including endosomes, lysosomes, autophagosomes, Golgi net-
work, and endoplasmic reticulum. It is becoming increasingly 
clear that proteins associated with these membrane compart-
ments play important roles in B cell activation and differentia-
tion. These processes can be regulated by microRNAs, which are 
important regulators of a wide range of cellular processes. 
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Lou et  al. discussed the regulation of B cell differentiation by 
intracellular membrane-associated proteins and their modula-
tion by microRNAs.
Altogether, these articles provide new and important infor-
mation for the understanding of how epigenetic marks/factors 
contribute to B cell development and differentiation, as well as 
the maturation of the antibody response. We are grateful for the 
efforts that the authors have made to help us compile this ebook 
for Frontiers in Immunology.
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